Premixed preparation for dexmedetomidine

A dexmedetomidine and premixing technology, applied in the field of ready-to-use premixed preparations, can solve the problems of rising impurities, hidden dangers of infusion safety, easy breakage, etc., so as to avoid pollution and excess, reduce infusion pollution, and be difficult to break. Effect

Inactive Publication Date: 2016-10-26
JIANGSU HENGRUI MEDICINE CO LTD
View PDF6 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, US8242158, US8338470, US8455527, and US8648106 pointed out that the use of some plastic packaging for this product is likely to cause a reduction in content and / or an increase in impurities
[0004] So far, ready-to-use premixed preparations containing dexmedetomidine have been packaged in glass bottles, and glass bottles have the following disadvantages: ①Infusion method: during the infusion process, it must be delivered to the outside through a ventilation tube connected to the outside world. Air is introduced into the bottle to generate pressure, and dust and microorganisms in the air can enter the glass bottle and cause infusion infection
②Glass bottle material: Glass bottles may fall off during the preparation of sterilized packaging and transportation, causing solid particles to enter the infusion or cracks and damage to cause infection. This kind of damage is not easy to detect, and it is often discovered after the patient has an infusion reaction. , which poses a great hidden danger to the safety of infusion
③During transportation and storage, glass bottled liquid occupies a large space and is easily broken, and it is easy to cause pollution due to difficult cleaning during production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Premixed preparation for dexmedetomidine
  • Premixed preparation for dexmedetomidine
  • Premixed preparation for dexmedetomidine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Example 1: Selection of ready-to-use premixed dexmedetomidine composition plastic packaging materials

[0029] Dissolve dexmedetomidine hydrochloride and sodium chloride in water for injection, respectively, to prepare a ready-to-use premixed solution containing 4 μg dexmedetomidine and 9 mg sodium chloride per milliliter, and filter through a 0.22 μ PVDF filter membrane Afterwards, 50 mL of the inner layer is divided into multi-layer co-extruded infusion soft bags made of different materials, and sterilized at 121 degrees for 15 minutes. The sterilized samples were placed under accelerated conditions (40°C / 75%RH) for stability investigation. The multi-layer co-extruded infusion soft bags with different inner layers are made by heat-sealing the infusion films from different manufacturers, including German Polysini APP114 (inner layer is polypropylene), German Polysini APP114-LP (inner The layer is polypropylene), Sealed Air's M312-C (modified ethylene / propylene polymer...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a premixed preparation for dexmedetomidine. Specifically, the invention relates to a ready-to-use premixed preparation of dexmedetomidine packaged in a container containing plastic or a pharmaceutically acceptable salt thereof. The ready-to-use premixed preparation can be used for sedation of patients in an intensive care unit or procedural sedation.

Description

technical field [0001] Dexmedetomidine or a pharmaceutically acceptable salt thereof packaged in a plastic-containing container according to the invention is a premixed, ready-to-use formulation that can be administered to patients in an intensive care unit (ICU) Sedation and sedation during operation (Procedural Sedation). Background technique [0002] Dexmedetomidine is an α2-adrenoceptor agonist, its chemical name is: (+)-4-(S)-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole . Dexmedetomidine is used for sedation of critically ill or injured patients in the ICU during initial intubation or mechanical ventilation during treatment, and can also be used for non-intubated patients during surgery or short-term sedation. [0003] Initially, dexmedetomidine was marketed as a concentrated injection of 200mcg / 2mL, which needed to be diluted before being administered to patients. Contains ready-to-use premixed formulations of dexmedetomidine (Precedex TM (dexmedetomidine hydrochlori...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4174A61J1/05B65D30/10
CPCA61K31/4174A61J1/05B65D31/02
Inventor 石晓磊孙飘扬赵静孙怡
Owner JIANGSU HENGRUI MEDICINE CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products